David Clair | Senior Director, Investor Relations and Corporate Development |
Chuck Kummeth | Chief Executive Officer |
Jim Hippel | Chief Financial Officer |
Puneet Souda | SVB Leerink |
Dan Arias | Stifel |
Jacob Johnson | Stephens |
Alex Nowak | Craig-Hallum |
Catherine Schulte | Baird |
Patrick Donnelly | Citi |
Paul Knight | KeyBanc Capital Markets |
Good morning and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2022. At this time all participants have been placed in listen-only mode and the call will be open for questions followed by managements prepared remarks.
During our Q&A session, please limit yourself to one question and one follow up. I would now like to turn the call over to David Clair, Bio-Techne's Senior Director, Investor Relations and Corporate Development.
Good morning and thank you for joining us.